2003
DOI: 10.1634/stemcells.21-4-472
|View full text |Cite
|
Sign up to set email alerts
|

Highly Efficient Lentiviral Gene Transfer in CD34 + and CD34 + /38 /lin Cells from Mobilized Peripheral Blood after Cytokine Prestimulation

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 51 publications
1
12
0
Order By: Relevance
“…The use of a low MOI is warranted for clinical trials, as the risk of insertional mutagenesis, also for lentiviral vectors, is present. A number of studies show that a higher MOI is needed for MPB than for cord blood to reach a sufficient transduction efficiency and that with an MOI of 100, gene transfer rates were obtained with a reasonable number of integration sites (a figure in the neighborhood of three to four copies per cell), thus limiting the risk of insertional oncogenesis [19]. In the present protocol, with an MOI of 50 we obtained a reasonable proportion of transduced cells, in which only 0.4 vector copies are integrated in the genome.…”
Section: Discussionmentioning
confidence: 99%
“…The use of a low MOI is warranted for clinical trials, as the risk of insertional mutagenesis, also for lentiviral vectors, is present. A number of studies show that a higher MOI is needed for MPB than for cord blood to reach a sufficient transduction efficiency and that with an MOI of 100, gene transfer rates were obtained with a reasonable number of integration sites (a figure in the neighborhood of three to four copies per cell), thus limiting the risk of insertional oncogenesis [19]. In the present protocol, with an MOI of 50 we obtained a reasonable proportion of transduced cells, in which only 0.4 vector copies are integrated in the genome.…”
Section: Discussionmentioning
confidence: 99%
“…35 Previously, we have successfully used an introndeleted version of this human promoter in human CD34 þ cells. 36,37 However, this short version was too weak to allow an efficient in vivo chemoprotection of transduced HSCs (preliminary data not shown). This study confirms the interest of the intron to reach a level of gene expression obtained as high as with a strong viral ESp but without acting as long-distance enhancers.…”
Section: Discussionmentioning
confidence: 99%
“…Expression of EGFP, CAT, and CuZn-SOD was driven by the human phosphoglycerate kinase promoter. Lentiviral particles were produced by transient transfection of 293T cells as described previously (27). The following plasmids were used: a packaging plasmid (pCMV⌬8.91), a vesicular somatitis virus glycoprotein (VSV-G) envelope plasmid pMD.G, and a transducing vector (TPW, TPEW, TPCATW, TPCuZnSODW).…”
Section: Methodsmentioning
confidence: 99%